{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:55:31Z","timestamp":1761742531339},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T00:00:00Z","timestamp":1110844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00259-004-1755-y","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T18:08:13Z","timestamp":1110823693000},"page":"742-748","source":"Crossref","is-referenced-by-count":126,"title":["Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy"],"prefix":"10.1007","volume":"32","author":[{"given":"Takako","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroji","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shizukuishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Endou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,15]]},"reference":[{"key":"1755_CR1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-5347(05)67370-3","volume":"164","author":"AE Wefer","year":"2000","unstructured":"Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000;164:400\u20134.","journal-title":"J Urol"},{"key":"1755_CR2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1148\/radiol.2231010575","volume":"223","author":"FV Coakley","year":"2002","unstructured":"Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002;223:91\u20137.","journal-title":"Radiology"},{"key":"1755_CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiology.202.3.9051019","volume":"202","author":"KK Yu","year":"1997","unstructured":"Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997;202:697\u2013702.","journal-title":"Radiology"},{"key":"1755_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2214\/ajr.176.1.1760017","volume":"176","author":"JR Thornbury","year":"2001","unstructured":"Thornbury JR, Ornstein DK, Choyke PL, Langlotz CP, Weinreb JC. Prostate cancer: what is the future role for imaging?. AJR Am J Roentgenol 2001;176:17\u201321.","journal-title":"AJR Am J Roentgenol"},{"key":"1755_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02995285","volume":"16","author":"T Inoue","year":"2002","unstructured":"Inoue T, Oriuchi N, Tomiyoshi K, Endo K. A shifting landscape: what will be next FDG in PET oncology? Ann Nucl Med 2002;16:1\u20139.","journal-title":"Ann Nucl Med"},{"key":"1755_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-4295(00)00896-7","volume":"57","author":"IJ Liu","year":"2001","unstructured":"Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 2001;57:108\u201311.","journal-title":"Urology"},{"key":"1755_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0022-5347(01)63916-8","volume":"159","author":"CK Hoh","year":"1998","unstructured":"Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Positron emission tomography in urological oncology. J Urol 1998;159:347\u201356.","journal-title":"J Urol"},{"key":"1755_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/nbm.1940050518","volume":"5","author":"W Negendank","year":"1992","unstructured":"Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303\u201324.","journal-title":"NMR Biomed"},{"key":"1755_CR9","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1016\/S0021-9258(18)88929-3","volume":"260","author":"CH Warden","year":"1985","unstructured":"Warden CH, Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem 1985;260:6006\u201311.","journal-title":"J Biol Chem"},{"key":"1755_CR10","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0022-3115(98)00315-8","volume":"39","author":"T Hara","year":"1998","unstructured":"Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990\u20135.","journal-title":"J Nucl Med"},{"key":"1755_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1148\/radiology.202.2.9015080","volume":"202","author":"N Shinoura","year":"1997","unstructured":"Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology 1997;202:497\u2013503.","journal-title":"Radiology"},{"key":"1755_CR12","first-page":"187","volume":"43","author":"T Hara","year":"2002","unstructured":"Hara T, Kosaka N, Kishi H. Development of F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 2002;43:187\u201399.","journal-title":"J Nucl Med"},{"key":"1755_CR13","first-page":"184","volume-title":"TNM classification of malignant tumours. 6th ed","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002. p 184\u20137."},{"key":"1755_CR14","first-page":"842","volume":"38","author":"T Hara","year":"1997","unstructured":"Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 1997;38:842\u20137.","journal-title":"J Nucl Med"},{"key":"1755_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1148\/radiol.2282011860","volume":"228","author":"HL Kundel","year":"2003","unstructured":"Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003;228:303\u20138.","journal-title":"Radiology"},{"key":"1755_CR16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2214\/ajr.166.4.8610547","volume":"166","author":"JA Baker","year":"1996","unstructured":"Baker JA, Kornguth PJ, Floyd CE. Breast imaging reporting and data system standardized mammography lexicon: observer variability in lesion description. AJR Am J Roentgenol 1996;166:773\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"1755_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1997","unstructured":"Landis JR, Kock GG. The measurement of observer agreement for categorical data. Biometrics 1997;33:159\u201374.","journal-title":"Biometrics"},{"key":"1755_CR18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.198.3.8628874","volume":"198","author":"J Kurhanewicz","year":"1996","unstructured":"Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24\u20130.7-cm3) spatial resolution. Radiology 1996;198:795\u2013805.","journal-title":"Radiology"},{"key":"1755_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-5347(17)40079-6","volume":"143","author":"AW Partin","year":"1990","unstructured":"Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990;143:747\u201352.","journal-title":"J Urol"},{"key":"1755_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","volume":"23","author":"DF Gleason","year":"1992","unstructured":"Gleason DF. Histopathologic grading of prostatic cancer: a perspective. Hum Pathol 1992;23:273\u20139.","journal-title":"Hum Pathol"},{"key":"1755_CR21","first-page":"82S","volume":"45","author":"RL Wahl","year":"2004","unstructured":"Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET\/CT. J Nucl Med 2004;45:82S\u201395S.","journal-title":"J Nucl Med"},{"key":"1755_CR22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00259-003-1377-9","volume":"31","author":"E Sutinen","year":"2004","unstructured":"Sutinen E, Nurmi M, Roivainen A, Varpula M, Torvanen T, Lehikoinen P, et al. Kinetics of [11C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging 2004;31:317\u201324.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1755_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1148\/radiology.189.2.8210358","volume":"189","author":"ML Sciebler","year":"1993","unstructured":"Sciebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993;189:339\u201352.","journal-title":"Radiology"},{"key":"1755_CR24","first-page":"1228","volume":"8","author":"MJ Janssen","year":"1993","unstructured":"Janssen MJ, Huijgens PC, Bouman AA, Oe PL, Donker AJ, van der Meulen J. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Transplant 1993;8:1228\u201333.","journal-title":"Nephrol Dial Transplant"},{"key":"1755_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1148\/radiology.195.2.7724756","volume":"195","author":"S White","year":"1995","unstructured":"White S, Hricak H, Forstner R, Kuhanewicz J, Vigneron DB, Zaloudek CJ, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195:385\u201390.","journal-title":"Radiology"},{"key":"1755_CR26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0037-198X(05)80114-2","volume":"28","author":"P Ramchandani","year":"1993","unstructured":"Ramchandani P, Schnall MD. Magnetic resonance imaging of the prostate. Semin Roentgenol 1993;28:74\u201382.","journal-title":"Semin Roentgenol"},{"key":"1755_CR27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiology.206.3.9494502","volume":"206","author":"Y Kaji","year":"1998","unstructured":"Kaji Y, Kuhanewicz J, Hricak H, Sokolov DL, Huang LR, Nelson SJ, et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology 1998;206:785\u201390.","journal-title":"Radiology"},{"key":"1755_CR28","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0022-5347(01)62256-0","volume":"160","author":"JB Rietbergen","year":"1998","unstructured":"Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels WJ, Schroder FH. Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer. J Urol 1998;160:2121\u20135.","journal-title":"J Urol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-004-1755-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-004-1755-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-004-1755-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T22:10:00Z","timestamp":1625609400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-004-1755-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,15]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["1755"],"URL":"https:\/\/doi.org\/10.1007\/s00259-004-1755-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,15]]}}}